We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade
Read MoreHide Full Article
In the latest close session, Oscar Health, Inc. (OSCR - Free Report) was down 1.26% at $14.84. This change lagged the S&P 500's daily gain of 0.46%. On the other hand, the Dow registered a gain of 0.17%, and the technology-centric Nasdaq increased by 0.57%.
The company's shares have seen a decrease of 8.85% over the last month, not keeping up with the Finance sector's gain of 5.73% and the S&P 500's gain of 4.22%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is expected to report EPS of -$0.84, down 35.48% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.21 billion, indicating a 33.98% increase compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$1.35 per share and revenue of $12.1 billion. These totals would mark changes of -1450% and +31.86%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 2.88% rise in the Zacks Consensus EPS estimate. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 44, placing it within the top 18% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Slides as Market Rises: Facts to Know Before You Trade
In the latest close session, Oscar Health, Inc. (OSCR - Free Report) was down 1.26% at $14.84. This change lagged the S&P 500's daily gain of 0.46%. On the other hand, the Dow registered a gain of 0.17%, and the technology-centric Nasdaq increased by 0.57%.
The company's shares have seen a decrease of 8.85% over the last month, not keeping up with the Finance sector's gain of 5.73% and the S&P 500's gain of 4.22%.
Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is expected to report EPS of -$0.84, down 35.48% from the prior-year quarter. Meanwhile, the latest consensus estimate predicts the revenue to be $3.21 billion, indicating a 33.98% increase compared to the same quarter of the previous year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$1.35 per share and revenue of $12.1 billion. These totals would mark changes of -1450% and +31.86%, respectively, from last year.
Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system, spanning from #1 (Strong Buy) to #5 (Strong Sell), boasts an impressive track record of outperformance, audited externally, with #1 ranked stocks yielding an average annual return of +25% since 1988. Over the past month, there's been a 2.88% rise in the Zacks Consensus EPS estimate. Currently, Oscar Health, Inc. is carrying a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 44, placing it within the top 18% of over 250 industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.